Monday, October 31, 2022 Call to Action: Diversity and Inclusion in Biopharmaceutical Market Research Intellus has teamed with representatives across biopharmaceutical companies, insights consulting firms, and fieldwork agencies to address gaps in the industry and how to bring greater diversity, equity and inclusion to healthcare insights and analytics. In this first thought piece, we detail what has been missing from biopharma market research insights, and what the impact has been in terms of both commercial strategy and patient access to treatment and care. In our second paper, we will detail potential solutions to guide the industry in ensuring a DEI lens is applied to insights work – from the initial scoping and planning, through to design, execution, analysis, and delivery. Read full paper here.